Outlook Therapeutics shares owned by Charles Schwab Investment Management
Quarter-by-quarter ownership of Outlook Therapeutics shares owned by Charles Schwab Investment Management
from 13F filings
Historical chart of Charles Schwab Investment Management investment in Outlook Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Outlook Therapeutics held by Charles Schwab Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Outlook Therapeutics by Charles Schwab Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $140k | 355k | 0.39 |
| 2023-09-30 | $78k | 355k | 0.22 |
| 2023-06-30 | $726k | 417k | 1.74 |
| 2023-03-31 | $449k | 412k | 1.09 |
| 2022-12-31 | $356k | 329k | 1.08 |
| 2022-09-30 | $402k | 329k | 1.22 |
| 2022-06-30 | $338k | 331k | 1.02 |
| 2022-03-31 | $564k | 317k | 1.78 |
| 2021-12-31 | $300k | 220k | 1.36 |
| 2021-09-30 | $478k | 220k | 2.17 |
| 2021-06-30 | $548k | 220k | 2.49 |
| 2021-03-31 | $78k | 34k | 2.27 |